• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Weakness (2145); Stenosis (2263)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.
 
Event Description
It was reported that on (b)(6) 2013 the patient underwent anterior cervical discectomy and fusion- extrapharangeal anterolateral approach.Levels implanted: c4-c5, c5-c6, c6-c7.Preoperative diagnosis: degenerative disc disease.Following mentioned are the adverse events occurred: ae#1: event date: (b)(6) 2014 primary diagnosis: weakness in right hand followed overtime by pain in right deltoid, for past few months.Hospitalizations: date of admission: (b)(6) 2014; discharge date: (b)(6) 2014 other actions: the patient underwent hemilaminectomies and foraminotomy c7-t1 for nerve decompression, tolerated without adversity.Relatedness: not related severity: severe outcome: unknown ae#2: event date: (b)(6) 2015 primary diagnosis: weakness in fingers of right hand with global <(>&<)> progressive loss of function in right hand hospitalizations: date of admission: (b)(6) 2014; discharge date: (b)(6) 2014 other actions: the patient underwent acdf c7-t1 at outside hospital.Relatedness: not related severity: severe outcome: unknown ae#3: event date: (b)(6) 2015 primary diagnosis: lost his voice hospitalizations: date of admission: (b)(6) 2014; discharge date: (b)(6) 2014 other actions: the patient referred self to local ent specialist who told that patient had vocal cord paralysis.Patient was scheduled to collagen injection.Relatedness: not related severity: moderate outcome: unknown diagnostic test: a) lateral cervical spine radiographs: (b)(6) 2015; results: normal.Mri without contrast cervical spine: (b)(6) 2014; results: abnormal, right foraminal encroachment/possible disc herniation, c7-t1.Mri without contrast cervical spine: (b)(6) 2014: results: abnormal, right foraminal stenosis, c7-t1.Electromyelograph with nerve conduction studies: (b)(6) 2014; results: abnormal, worsening c8 radiculopathy.
 
Event Description
It was reported that ae#2: event occurrence: (b)(6) 2015 primary diagnosis: progressive c8 radiculopathy, recalcitrant to nonoperative therapy.Diagnostic test: lateral cervical spine radiographs: (b)(6) 2015; results: normal.Mri without contrast cervical spine: (b)(6) 2014; results: abnormal, right foraminal encroachment/possible disc herniation, c7-t1.Mri without contrast cervical spine: (b)(6) 2014: results: abnormal, right foraminal stenosis, c7-t1.Electromyelograph with nerve conduction studies: (b)(6) 2014; results: abnormal, worsening c8 radiculopathy.Hospitalizations: date of admission: (b)(6) 2014; discharge date: (b)(6) 2014.Length of hospitalization: greater than 24 hours.Surgical treatments: no.Othet actions: the patient underwent acdf c7-t1 at outside hospital.Relatedness: not related severity: severe; sae: yes; outcome: unknown ae#3: primary diagnosis (modified): vocal cord paralysis hospitalizations: date of admission: (b)(6) 2014; discharge date: (b)(6) 2014, length of hospitalization: greater than 24 hours.Surgical treatments: no.Relatedness: undetermined sae: no.
 
Event Description
It was reported that on ae#3: primary diagnosis (modified): vocal cord paralysis hospitalizations: date of admission: on (b)(6) 2014; discharge date: on (b)(6) 2014, length of hospitalization: greater than 24 hours.Surgical treatments: no.Relatedness: undetermined sae: no.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
greg anglin
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key6029582
MDR Text Key57421800
Report Number1030489-2016-02895
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 11/15/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/14/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received11/15/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age67 YR
Patient Weight91
-
-